User profiles for Albert Prats Uribe
Albert Prats-UribeCentre for Statistics in Medicine, NDORMS, University of Oxford Verified email at ndorms.ox.ac.uk Cited by 1872 |
[HTML][HTML] Renin–angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis
Background Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor
blockers (ARBs) have been postulated to affect susceptibility to COVID-19. Observational …
blockers (ARBs) have been postulated to affect susceptibility to COVID-19. Observational …
Clinical and genetic risk factors for acute incident venous thromboembolism in ambulatory patients with COVID-19
Importance The risk of venous thromboembolism (VTE) in ambulatory COVID-19 is controversial.
In addition, the association of vaccination with COVID-19–related VTE and relevant …
In addition, the association of vaccination with COVID-19–related VTE and relevant …
Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self …
Background Hydroxychloroquine has recently received Emergency Use Authorization by the
FDA and is currently prescribed in combination with azithromycin for COVID-19 pneumonia. …
FDA and is currently prescribed in combination with azithromycin for COVID-19 pneumonia. …
[HTML][HTML] Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study
Background Hydroxychloroquine, a drug commonly used in the treatment of rheumatoid
arthritis, has received much negative publicity for adverse events associated with its …
arthritis, has received much negative publicity for adverse events associated with its …
Global epidemiology of hip fractures: secular trends in incidence rate, post‐fracture treatment, and all‐cause mortality
…, N Ooba, AB Pedersen, A Prats‐Uribe… - Journal of Bone and …, 2023 - academic.oup.com
In this international study, we examined the incidence of hip fractures, postfracture treatment,
and all‐cause mortality following hip fractures, based on demographics, geography, and …
and all‐cause mortality following hip fractures, based on demographics, geography, and …
[HTML][HTML] The impact of the COVID-19 pandemic on Sexually Transmitted Infections surveillance data: incidence drop or artefact?
A Sentís, A Prats-Uribe, E López-Corbeto… - BMC public health, 2021 - Springer
Background Before the COVID-19 pandemic, Sexually transmitted infections (STIs) were
increasing in Europe, and Spain and Catalonia were not an exception. Catalonia has been one …
increasing in Europe, and Spain and Catalonia were not an exception. Catalonia has been one …
[HTML][HTML] The natural history of symptomatic COVID-19 during the first wave in Catalonia
The natural history of coronavirus disease 2019 (COVID-19) has yet to be fully described.
Here, we use patient-level data from the Information System for Research in Primary Care (…
Here, we use patient-level data from the Information System for Research in Primary Care (…
Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study
Objective To investigate the use of repurposed and adjuvant drugs in patients admitted to
hospital with covid-19 across three continents. Design Multinational network cohort study. …
hospital with covid-19 across three continents. Design Multinational network cohort study. …
[HTML][HTML] Thirty-day outcomes of children and adolescents with COVID-19: an international experience
OBJECTIVES To characterize the demographics, comorbidities, symptoms, in-hospital
treatments, and health outcomes among children and adolescents diagnosed or hospitalized with …
treatments, and health outcomes among children and adolescents diagnosed or hospitalized with …
[HTML][HTML] Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study
Comorbid conditions appear to be common among individuals hospitalised with coronavirus
disease 2019 (COVID-19) but estimates of prevalence vary and little is known about the …
disease 2019 (COVID-19) but estimates of prevalence vary and little is known about the …